ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,826Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 5176

$2.42M Total Retail Price of All Prescriptions

Rank: 30 out of 5176

614 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 614 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 16,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$136 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
EVISTA 780 743 1 65
METOPROLOL SUCCINATE 488 476 2 11
LOSARTAN POTASSIUM 472 438 3 14
NEXIUM 442 419 4 16
AMLODIPINE BESYLATE 438 400 5 2
LIDODERM 421 395 6 59
ATORVASTATIN CALCIUM 399 386 7 9
SIMVASTATIN 398 349 8 1
DIOVAN 398 360 8 19
METFORMIN HCL ER 364 315 10 57
PROAIR HFA 339 307 11 60
LOVAZA 319 302 12 43
FORTEO 315 312 13 264
ADVAIR DISKUS 309 287 14 32
ATENOLOL 304 263 15 12
OMEPRAZOLE 280 255 16 3
SYNTHROID 278 247 17 33
BYSTOLIC 269 267 18 96
CRESTOR 266 237 19 15
PATANOL 247 232 20 158
TAMSULOSIN HCL 199 191 21 20
PRANDIN 190 190 22 150
JANUVIA 177 141 23 25
ZETIA 172 147 24 68
GLIPIZIDE XL 170 158 25 83
FLUTICASONE PROPIONATE 167 150 26 38
CIPROFLOXACIN HCL 166 153 27 84
LYRICA 161 146 28 133
UNIFINE PENTIPS 161 153 10 28 261
ONGLYZA 160 135 30 153
AZITHROMYCIN 158 150 31 42
SINGULAIR 158 149 31 62
CELEBREX 151 142 33 80
AMMONIUM LACTATE 146 142 34 91
ALLOPURINOL 146 146 34 41
MECLIZINE HCL 143 138 36 81
TRIAMCINOLONE ACETONIDE 137 126 37 125
SPIRIVA 136 132 38 54
MELOXICAM 131 119 39 53
POTASSIUM CHLORIDE 131 123 39 34
TRAMADOL HCL-ACETAMINOPHEN 129 121 41 116
ACTOS 126 110 42 85
TRILIPIX 125 125 43 187
LIPITOR 125 122 43 51
COMBIVENT 114 110 45 156
NIFEDIPINE ER 107 102 46 48
POLYETHYLENE GLYCOL 3350 104 96 47 74
PLAVIX 104 103 47 29
CEFUROXIME 102 92 49 273
BETAMETHASONE DIPROPIONATE 102 95 49 260
CLOBETASOL PROPIONATE 100 96 51 130
WELCHOL 95 81 52 230
ALENDRONATE SODIUM 93 78 53 18
BENICAR 92 86 54 100
FUROSEMIDE 89 86 55 8
COLCRYS 89 89 55 170
CLOPIDOGREL 87 78 57 26
MICARDIS 86 86 58 154
VOLTAREN 86 83 58 97
DOXYCYCLINE HYCLATE 86 81 58 247
ZOSTAVAX 82 73 61 219
LIDOCAINE 80 77 62 179
SYMBICORT 80 75 62 120
DIOVAN HCT 79 79 64 39
AVODART 79 79 64 107
SINGLE USE SWAB 78 77 66 108
CEFDINIR 77 66 67 396
URSODIOL 77 62 67 405
MONTELUKAST SODIUM 75 72 69 123
MICARDIS HCT 74 74 70 180
BARACLUDE 74 73 70 373
ACTONEL 72 71 72 134
LEVOTHYROXINE SODIUM 72 65 72 4
ENALAPRIL MALEATE 71 53 74 22
GABAPENTIN 70 65 75 21
METFORMIN HCL 69 67 76 7
DONEPEZIL HCL 66 66 77 28
AMOX TR-POTASSIUM CLAVULANATE 64 54 78 141
GLYBURIDE-METFORMIN HCL 62 35 R 79 76
SUCRALFATE 60 49 80 303
CLOTRIMAZOLE-BETAMETHASONE 59 58 81 94
MUPIROCIN 57 52 82 182
LOSARTAN-HYDROCHLOROTHIAZIDE 55 47 83 35
DIGOXIN 53 53 84 56
LISINOPRIL 53 53 84 5
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.